Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Cash: 2016-2024

Historic Change in Cash for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $31.8 million.

  • Organogenesis Holdings' Change in Cash fell 310.45% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 683.64%. This contributed to the annual value of $31.8 million for FY2024, which is 2935.59% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Change in Cash is $31.8 million, which was up 2,935.59% from $1.0 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Change in Cash ranged from a high of $31.8 million in FY2024 and a low of -$11.2 million during FY2022.
  • For the 3-year period, Organogenesis Holdings' Change in Cash averaged around $7.2 million, with its median value being $1.0 million (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Change in Cash crashed by 137.81% in 2022, and later soared by 2,935.59% in 2024.
  • Organogenesis Holdings' Change in Cash (Yearly) stood at $24.4 million in 2020, then climbed by 21.63% to $29.7 million in 2021, then crashed by 137.81% to -$11.2 million in 2022, then spiked by 109.33% to $1.0 million in 2023, then skyrocketed by 2,935.59% to $31.8 million in 2024.